Filtered By:
Condition: Cough
This page shows you your search results in order of date. This is page number 13.
Order by Relevance | Date
Total 5181 results found since Jan 2013.
Is Post COVID-19 cholangiopathy an appropriate ındication for liver transplantation?
Rev Esp Enferm Dig. 2023 Jun 14. doi: 10.17235/reed.2023.9740/2023. Online ahead of print.ABSTRACTThe effect of severe acute respiratory syndrome coronavirus-2, which has infected more than 765 million people in the world to date, has decreased gradually, but the effect of late complications after the disease has begun to increase. Post-coronavirus disease 2019 cholangiopathy can be considered as one of the late complications identified in patients recovering from SARS-CoV-2 infection. A 38-year-old man was admitted to our emergency department with fever up to 39,5ºC, dry cough, anosmia, and dyspnea for 4 days. In the che...
Source: Revista Espanola de Enfermedades Digestivas - June 14, 2023 Category: Gastroenterology Authors: Mevlut Kiyak Recep Ayhan Mehtap Yavuz Cemile Demirtas Serdal Çakmak Erhan Altun öz Serkan İpek Source Type: research
Combined REGN-COV2 Antibody Therapy Immediately Prevented a Patient with Refractory Type 1 Autoimmune Pancreatitis from Contracting SARS-CoV-2 during the Sixth Wave in Japan
Intern Med. 2023;62(12):1765-1770. doi: 10.2169/internalmedicine.1421-22. Epub 2023 Jun 15.ABSTRACTA 51-year-old man who had been receiving steroid therapy for type 1 autoimmune pancreatitis (AIP) for 3 years contracted coronavirus disease 2019 (COVID-19). As he had a high-grade fever and dry cough, and because his SpO2 level had dropped below 95% in the supine position, he was considered as being at a high risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); therefore, he received combined REGN-COV2 antibody therapy. The patient's fever resolved immediately after this treatment, and he went into remissio...
Source: Internal Medicine - June 14, 2023 Category: Internal Medicine Authors: Chihiro Katsuso Kensuke Kubota Katsushi Tanaka Yusuke Kurita Atsushi Nakajima Source Type: research
Is Post COVID-19 cholangiopathy an appropriate ındication for liver transplantation?
Rev Esp Enferm Dig. 2023 Jun 14. doi: 10.17235/reed.2023.9740/2023. Online ahead of print.ABSTRACTThe effect of severe acute respiratory syndrome coronavirus-2, which has infected more than 765 million people in the world to date, has decreased gradually, but the effect of late complications after the disease has begun to increase. Post-coronavirus disease 2019 cholangiopathy can be considered as one of the late complications identified in patients recovering from SARS-CoV-2 infection. A 38-year-old man was admitted to our emergency department with fever up to 39,5ºC, dry cough, anosmia, and dyspnea for 4 days. In the che...
Source: Revista Espanola de Enfermedades Digestivas - June 14, 2023 Category: Gastroenterology Authors: Mevlut Kiyak Recep Ayhan Mehtap Yavuz Cemile Demirtas Serdal Çakmak Erhan Altun öz Serkan İpek Source Type: research
Combined REGN-COV2 Antibody Therapy Immediately Prevented a Patient with Refractory Type 1 Autoimmune Pancreatitis from Contracting SARS-CoV-2 during the Sixth Wave in Japan
Intern Med. 2023;62(12):1765-1770. doi: 10.2169/internalmedicine.1421-22. Epub 2023 Jun 15.ABSTRACTA 51-year-old man who had been receiving steroid therapy for type 1 autoimmune pancreatitis (AIP) for 3 years contracted coronavirus disease 2019 (COVID-19). As he had a high-grade fever and dry cough, and because his SpO2 level had dropped below 95% in the supine position, he was considered as being at a high risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); therefore, he received combined REGN-COV2 antibody therapy. The patient's fever resolved immediately after this treatment, and he went into remissio...
Source: Internal Medicine - June 14, 2023 Category: Internal Medicine Authors: Chihiro Katsuso Kensuke Kubota Katsushi Tanaka Yusuke Kurita Atsushi Nakajima Source Type: research
Is Post COVID-19 cholangiopathy an appropriate ındication for liver transplantation?
Rev Esp Enferm Dig. 2023 Jun 14. doi: 10.17235/reed.2023.9740/2023. Online ahead of print.ABSTRACTThe effect of severe acute respiratory syndrome coronavirus-2, which has infected more than 765 million people in the world to date, has decreased gradually, but the effect of late complications after the disease has begun to increase. Post-coronavirus disease 2019 cholangiopathy can be considered as one of the late complications identified in patients recovering from SARS-CoV-2 infection. A 38-year-old man was admitted to our emergency department with fever up to 39,5ºC, dry cough, anosmia, and dyspnea for 4 days. In the che...
Source: Revista Espanola de Enfermedades Digestivas - June 14, 2023 Category: Gastroenterology Authors: Mevlut Kiyak Recep Ayhan Mehtap Yavuz Cemile Demirtas Serdal Çakmak Erhan Altun öz Serkan İpek Source Type: research
Combined REGN-COV2 Antibody Therapy Immediately Prevented a Patient with Refractory Type 1 Autoimmune Pancreatitis from Contracting SARS-CoV-2 during the Sixth Wave in Japan
Intern Med. 2023;62(12):1765-1770. doi: 10.2169/internalmedicine.1421-22. Epub 2023 Jun 15.ABSTRACTA 51-year-old man who had been receiving steroid therapy for type 1 autoimmune pancreatitis (AIP) for 3 years contracted coronavirus disease 2019 (COVID-19). As he had a high-grade fever and dry cough, and because his SpO2 level had dropped below 95% in the supine position, he was considered as being at a high risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); therefore, he received combined REGN-COV2 antibody therapy. The patient's fever resolved immediately after this treatment, and he went into remissio...
Source: Internal Medicine - June 14, 2023 Category: Internal Medicine Authors: Chihiro Katsuso Kensuke Kubota Katsushi Tanaka Yusuke Kurita Atsushi Nakajima Source Type: research
Is Post COVID-19 cholangiopathy an appropriate ındication for liver transplantation?
Rev Esp Enferm Dig. 2023 Jun 14. doi: 10.17235/reed.2023.9740/2023. Online ahead of print.ABSTRACTThe effect of severe acute respiratory syndrome coronavirus-2, which has infected more than 765 million people in the world to date, has decreased gradually, but the effect of late complications after the disease has begun to increase. Post-coronavirus disease 2019 cholangiopathy can be considered as one of the late complications identified in patients recovering from SARS-CoV-2 infection. A 38-year-old man was admitted to our emergency department with fever up to 39,5ºC, dry cough, anosmia, and dyspnea for 4 days. In the che...
Source: Revista Espanola de Enfermedades Digestivas - June 14, 2023 Category: Gastroenterology Authors: Mevlut Kiyak Recep Ayhan Mehtap Yavuz Cemile Demirtas Serdal Çakmak Erhan Altun öz Serkan İpek Source Type: research
Evolution of the newest diagnostic methods for COVID-19: a Chinese perspective
J Zhejiang Univ Sci B. 2023 Jun 15;24(6):463-484. doi: 10.1631/jzus.B2200625.ABSTRACTCoronavirus disease 2019 (COVID-19) has continued to spread globally since late 2019, representing a formidable challenge to the world's healthcare systems, wreaking havoc, and spreading rapidly through human contact. With fever, fatigue, and a persistent dry cough being the hallmark symptoms, this disease threatened to destabilize the delicate balance of our global community. Rapid and accurate diagnosis of COVID-19 is a prerequisite for understanding the number of confirmed cases in the world or a region, and an important factor in epide...
Source: J Zhejiang Univ Sci ... - June 13, 2023 Category: Science Authors: Mingtao Liu Jiali Lyu Xianhui Zheng Zhiman Liang Baoying Lei Huihuang Chen Yiyin Mai Huimin Huang Baoqing Sun Source Type: research
